Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for Patent: 3,666,858

« Back to Dashboard

Summary for Patent: 3,666,858

Abstract:Methods of using certain 13-ethyl-gon-4-enes are described, namely 13.beta.,17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one, and the decanoate ester of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one for growth stimulation in mammals; and 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one, to treat dysfunctions of the female reproductive system in mammals, to control cyclic regularity, and to prevent conception in female mammals.
Inventor(s): Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA)
Assignee: SAID Smith, by said Hughes (N/A)
Application Number:04/649,800
Patent Claim Types:
see list of patent claims
Composition; Use;

No matches for this query

International Patent Family for Patent: 3,666,858

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium716736► Subscribe
Cyprus658► Subscribe
Denmark130949► Subscribe
United Kingdom1204171► Subscribe
United Kingdom1204172► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.